| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |